NCT05255120

Brief Summary

Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences in preoperative information, planning of surgery and surgical technique. A structured approach including the use of mobile phone technology can possibly improve patient information and patient involvement. Our purpose is to to evaluate whether systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 4, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 4, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

4.1 years

First QC Date

February 4, 2022

Last Update Submit

December 10, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Unexpected postoperative symtoms

    Proportion of patients with unexpected symptoms.

    Up to one year postoperatively

  • Proportion minimally invasive hysterectomy

    Proportion of women undergoing hysterectomy as a minimally invasive procedure

    Retrospecive data 5 years before study start until completion of prospective study

Secondary Outcomes (5)

  • Complication

    Up to one year postoperatively

  • Lenght of stay

    Day of surgery until discharge from hospital pre- and during the intervention

  • Sick leave

    Day of discharge from hospital after surgery until return to normal work, maximal one year

  • Recovery

    Day of surgery until normal ADL, maximal one year

  • Health related quality of life

    Preoperatively up to one year postoperatively

Study Arms (2)

Intensified preoperative information

EXPERIMENTAL

The patient participating in the intervention group is evaluated preoperatively based on an algorithm. This information is designed according to a checklist which includes how the procedure is performed, rules of conduct in connection with and after the procedure and what the patient can expect after surgery.

Other: Intiensified structured perioperative information

Control group

NO INTERVENTION

The patient who participates in the control group receives information about participation in the study as a control, ie without information about the intervention. The patient will then be planned for the procedure according to current, local routines.

Interventions

The doctor takes a medical history and examines the patient according to regular routines, but uses the algorithm as support in deciding on the surgical method. After the doctor's visit, the patient must see a research nurse to receive the intensified preoperative information about hysterectomy. This information is designed according to a checklist. The patient can also download a mobile application. The study-specific mobile application (app) contains information about hysterectomy. The information is structured in three parts - Before the Operation, At the Hospital and After the Operation. A timeline describes the activities and events that occur before, around and after the operation. Within each section there are several information links, with eg checklists.

Intensified preoperative information

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients undergoing hysterectomy
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women 18 - 55 years old.
  • Women undergoing hysterectomy for benign indication.
  • Women with ASA 1 - 3.
  • Women who understand and can express themselves in Swedish.
  • Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.
  • Women who participate and respond to the surveys in the GynOp register.
  • Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).

You may not qualify if:

  • Women where both ovaries are removed during the operation.
  • Women undergoing hysterectomy for prolapse indication.
  • Women undergoing hysterectomy for cancer prophylactic indication.
  • Women undergoing hysterectomy for gender reassignment purposes.
  • Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.
  • Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital

Linköping, 58185, Sweden

Location

Vrinnevisjukhuset

Norrköping, 58185, Sweden

Location

Related Publications (1)

  • Bjorkstrom LM, Wodlin NB, Nilsson L, Kjolhede P. The Impact of Preoperative Assessment and Planning on the Outcome of Benign Hysterectomy - a Systematic Review. Geburtshilfe Frauenheilkd. 2021 Feb;81(2):200-213. doi: 10.1055/a-1263-0811. Epub 2021 Feb 8.

    PMID: 33574624BACKGROUND

Study Officials

  • Preben Kjölhede, MD PhD

    University Hospital, Linköing

    STUDY CHAIR
  • Lollo Makdessi, MD

    Vrinnevi Hospital, Norrköping

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 4, 2022

First Posted

February 24, 2022

Study Start

September 4, 2020

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations